News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
European Union Revises Clinical Trial Regulations to Enhance Patient Safety and Data Transparency
Saturday, August 30, 2025
European Biopharma Industry Leads Global Growth with Increased R&D Investments
Saturday, August 30, 2025
Veeva Partners with Amgen to Drive Innovation in Clinical Trials
Friday, August 29, 2025Veeva Systems has announced a collaboration with biotechnology company Amgen to advance clinical trial innovation Amgen will use the Veeva Clinical Platform to streamline trial processes and improve efficiency
D3 Bio Receives FDA Breakthrough Therapy and Orphan Drug Designations for D3S-001 in KRAS G12C-Mutated Cancers
Friday, August 29, 2025D Bio a clinicalstage oncology company developing precision cancer therapies has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to DS
Genmab Secures FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced Endometrial Cancer
Thursday, August 28, 2025Genmab AS has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for rinatabart sesutecan RinaS The investigational folate receptor alpha FRdirected
Travere Therapeutics Receives FDA Approval for REMS Update on FILSPARI® (sparsentan) in IgA Nephropathy
Thursday, August 28, 2025Travere Therapeutics Inchas announced that the US Food and Drug Administration FDA has approved modifications to the Risk Evaluation and Mitigation Strategy REMS for FILSPARI sparsentan the only dual endothelin angiotensin receptor antagonist approve...
Ayrmid Ltd. receives FDA acceptance and priority review for omidubicel in Severe Aplastic Anaemia
Tuesday, August 26, 2025Ayrmid Ltd the parent company of Gamida Cell Inc has announced that the US Food and Drug Administration FDA has accepted its supplementary Biologics License Application sBLA for omidubicel in the treatment
Roche’s US subsidiary Genentech begins construction of advanced manufacturing facility in North Carolina
Tuesday, August 26, 2025Genentech part of the Roche Group has started construction on a new manufacturing site in Holly Springs North Carolina This marks the companys first production facility on the East Coast of the United States
Johnson & Johnson Expands U.S. Presence with $2 Billion Investment in North Carolina Facility
Friday, August 22, 2025Johnson Johnsonhas confirmed a billion commitment over the next decade to expand its US manufacturing capacity through a new partnership with FUJIFILM The investment will support the establishment
Crinetics Gains FDA Orphan Drug Designation for Atumelnant in Congenital Adrenal Hyperplasia (CAH)
Friday, August 22, 2025Crinetics Pharmaceuticals Inc has received Orphan Drug Designation ODD from the US Food and Drug Administration FDA for atumelnant a oncedaily oral adrenocorticotropic hormone ACTH receptor antagonist
